These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25392441)

  • 1. Giant inverted T waves and substantial QT interval prolongation induced by azithromycin in an elderly woman with renal insufficiency.
    Yu T; Niu T
    Can Fam Physician; 2014 Nov; 60(11):1012-5. PubMed ID: 25392441
    [No Abstract]   [Full Text] [Related]  

  • 2. Azithromycin-induced QT prolongation in elderly patient.
    Russo V; Puzio G; Siniscalchi N
    Acta Biomed; 2006 Apr; 77(1):30-2. PubMed ID: 16856707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic ventricular tachycardia with a normal QT interval following azithromycin.
    Kim MH; Berkowitz C; Trohman RG
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1221-2. PubMed ID: 16359290
    [No Abstract]   [Full Text] [Related]  

  • 6. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate prescribing of azithromycin for community-acquired pneumonia.
    Qian S; Siu J; Hussein A; Zheng Y
    Intern Med J; 2022 Jun; 52(6):1079-1082. PubMed ID: 35608398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of QT-interval prolongation precipitated by azithromycin.
    Matsunaga N; Oki Y; Prigollini A
    N Z Med J; 2003 Nov; 116(1185):U666. PubMed ID: 14615808
    [No Abstract]   [Full Text] [Related]  

  • 9. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Intravenous Azithromycin on the QT Interval of ICU Patients.
    Oberlander SR; Wall GC
    J Pharm Pract; 2024 Oct; 37(5):1055-1060. PubMed ID: 37939272
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrolides in community-acquired pneumonia: does the bell toll for thee?
    Granowitz EV; Brown RB
    Chest; 2005 Sep; 128(3):1089-93. PubMed ID: 16162689
    [No Abstract]   [Full Text] [Related]  

  • 12. QT interval prolongation and extreme bradycardia after a single dose of azithromycin.
    Santos N; Oliveira M; Galrinho A; Oliveira JA; Ferreira L; Ferreira R
    Rev Port Cardiol; 2010 Jan; 29(1):139-42. PubMed ID: 20391905
    [No Abstract]   [Full Text] [Related]  

  • 13. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
    Strle F; Maraspin V
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute onset of widespread pustular eruption.
    Pereira A; Pinho Â; Sousa P; Morais P
    Aust Fam Physician; 2015 Jun; 44(6):379-81. PubMed ID: 26209988
    [No Abstract]   [Full Text] [Related]  

  • 17. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Halpern MT; Cifaldi MA
    Clin Infect Dis; 2004 Jul; 39(1):144-5; author reply 145-6. PubMed ID: 15206068
    [No Abstract]   [Full Text] [Related]  

  • 18. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study.
    Kuzman I; Soldo I; Schönwald S; Culig J
    Scand J Infect Dis; 1995; 27(5):503-5. PubMed ID: 8588143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
    Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB
    Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.